Chang M C, Chen T H, Lo W H
Department of Orthopedics and Traumatology, Veterans General Hospital-Taipei, Taiwan, R.O.C.
Zhonghua Yi Xue Za Zhi (Taipei). 1997 Sep;60(3):130-6.
The application of core decompression in the treatment of ischemic necrosis of femoral head (INFH) is to preserve the joint at early stage of the disease. Although excellent results have been obtained in many series, its effectiveness is questionable because of high rates of failure. This study is to evaluate the effectiveness of this technique in our patients with INFH receiving core decompression as the sole treatment.
Although 91 patients were treated with core decompression in Veterans General Hospital-Taipei from 1980 to 1993, only 71 were considered as the valid cases after having been followed for 24 to 165 months (mean 56.7 months). Of 84 hips treated, 49 hips were steroid induced, 20 idiopathic, 14 alcohol related, and one related to trauma. Twenty-five hips were at Steinberg stage I, 32 at stage II, nine at stage III, 17 at stage IV, and one at stage VI.
The results were poor in 22 (26.19%) hips since the patients required hip prosthesis. Fair results were rated in 37 (44.05%) hips since progressive collapse occurred in the femoral head and the patients suffered from moderate hip pain. Good results were found in nine (10.71%) hips since the lesion showed no progression and the patients had only occasional pain. Excellent results were obtained in 16 (19.05%) hips since the patients had no pain and the lesion had no progressive change. The satisfactory rate in the nonsteroid-related hips (33% or 12/35) was significantly higher than in the steroid-related hips (27% or 13/49). The overall satisfactory result was only 30%.
Although core decompression may not be effective in preventing progression of INFH, it may relieve temporary pain and delays the need for hip arthroplasty in some patients.
在股骨头缺血性坏死(INFH)的治疗中应用髓芯减压术是为了在疾病早期保留关节。尽管在许多系列研究中都取得了优异的结果,但由于失败率较高,其有效性仍受到质疑。本研究旨在评估该技术对接受髓芯减压术作为唯一治疗方法的INFH患者的有效性。
1980年至1993年期间,台北荣民总医院有91例患者接受了髓芯减压术治疗,但在随访24至165个月(平均56.7个月)后,仅有71例被视为有效病例。在接受治疗的84个股骨头中,49个是由类固醇引起的,20个是特发性的,14个与酒精有关,1个与创伤有关。25个股骨头处于斯坦伯格I期,32个处于II期,9个处于III期,17个处于IV期,1个处于VI期。
22个股骨头(26.19%)的结果较差,因为患者需要进行髋关节置换。37个股骨头(44.05%)的结果为尚可,因为股骨头发生了进行性塌陷,患者遭受中度髋关节疼痛。9个股骨头(10.71%)的结果良好,因为病变没有进展,患者仅偶尔疼痛。16个股骨头(19.05%)的结果优异,因为患者没有疼痛且病变没有进行性变化。非类固醇相关股骨头的满意率(33%或12/35)显著高于类固醇相关股骨头(27%或13/49)。总体满意结果仅为30%。
尽管髓芯减压术可能无法有效预防INFH的进展,但它可能缓解部分患者的临时疼痛并延迟髋关节置换的需求。